See how arfolitixorin
works in cancer cells

See the animation

Pivotal Phase III study

First patient enrolled in Isofol’s AGENT study
in 1st line metastatic colorectal cancer

Read More

Arfolitixorin - a drug candidate
for treatment of colorectal cancer

Read more

More than 370 000 CRC patients
could be treated
with arfolitixorin

Read more

Previous

Next

Startpage 2

Upcoming Events